SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 230 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $441,523 | +141.3% | 12,378 | +128.6% | 0.06% | +6.8% |
| Q3 2022 | $183,000 | -99.9% | 5,414 | +4.3% | 0.06% | +18.0% |
| Q2 2022 | $150,095,000 | +102704.8% | 5,190 | +14.8% | 0.05% | +28.2% |
| Q1 2022 | $146,000 | +139.3% | 4,519 | +98.9% | 0.04% | +77.3% |
| Q3 2021 | $61,000 | +19.6% | 2,272 | +37.2% | 0.02% | +15.8% |
| Q2 2021 | $51,000 | +96.2% | 1,656 | +65.4% | 0.02% | +26.7% |
| Q1 2021 | $26,000 | – | 1,001 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 7,641,250 | $107,207,000 | 7.06% |
| HealthInvest Partners AB | 782,746 | $10,982,000 | 6.50% |
| KOPP INVESTMENT ADVISORS LLC | 729,960 | $10,241,000 | 5.51% |
| Murphy Michael R | 1,028,304 | $14,427,000 | 4.96% |
| Opaleye Management Inc. | 460,000 | $6,454,000 | 3.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 511,244 | $7,173,000 | 1.68% |
| Bruce & Co., Inc. | 394,581 | $5,535,000 | 1.42% |
| AlphaOne Investment Services, LLC | 235,065 | $3,297,000 | 1.40% |
| Ranger Investment Management | 1,560,453 | $21,893,000 | 1.23% |
| NORTHPOINTE CAPITAL LLC | 584,753 | $8,204,000 | 1.07% |